These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32052117)
1. [What does the nonradiologist expect from the radiologist?]. Kasper S; Virchow I; Hadaschik B; Radtke JP Radiologe; 2020 May; 60(5):421-429. PubMed ID: 32052117 [TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367 [TBL] [Abstract][Full Text] [Related]
3. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP. Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945 [TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
6. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI. Chavdarova LI; Tzonevska AD; Piperkova EN Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584 [TBL] [Abstract][Full Text] [Related]
7. Current Status of Hybrid PET/MRI in Oncologic Imaging. Rosenkrantz AB; Friedman K; Chandarana H; Melsaether A; Moy L; Ding YS; Jhaveri K; Beltran L; Jain R AJR Am J Roentgenol; 2016 Jan; 206(1):162-72. PubMed ID: 26491894 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185 [TBL] [Abstract][Full Text] [Related]
9. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [TBL] [Abstract][Full Text] [Related]
10. Role of positron emission tomography in thyroid and neuroendocrine tumors. Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone. Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207 [TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist. Beadsmoore C; Newman D; MacIver D; Pawaroo D Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234 [TBL] [Abstract][Full Text] [Related]
13. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study. Schwartz M; Gavane SC; Bou-Ayache J; Kolev V; Zakashansky K; Prasad-Hayes M; Taouli B; Chuang L; Kostakoglu L Abdom Radiol (NY); 2018 Dec; 43(12):3462-3467. PubMed ID: 29948057 [TBL] [Abstract][Full Text] [Related]
14. Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging. Al-Bayati M; Grueneisen J; Lütje S; Sawicki LM; Suntharalingam S; Tschirdewahn S; Forsting M; Rübben H; Herrmann K; Umutlu L; Wetter A Urol Int; 2018; 100(2):164-171. PubMed ID: 29393268 [TBL] [Abstract][Full Text] [Related]
15. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy. Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572 [TBL] [Abstract][Full Text] [Related]